Efficacy and Safety Study of SYR-619 in Treating Subjects With Type 2 Diabetes Mellitus
Status:
Terminated
Trial end date:
2007-02-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine the efficacy and safety of SYR-619, once daily
(QD), in subjects with type 2 diabetes mellitus who have not achieved glycemic control with
diet and exercise, or by taking metformin.